Kalal C, Joshi H, Zanwar S, Premkumar M. Tolvaptan Improves Refractory Ascites and Overall Survival in Cirrhosis: A Meta-Analysis. CIMRJ [Internet]. 2025 Jan. 31 [cited 2025 Mar. 11];6(1):65-73. Available from: https://e-journal.unair.ac.id/CIMRJ/article/view/60741